HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D D Bigner Selected Research

D D Bigner Research Topics

Disease

17Neoplasms (Cancer)
09/2010 - 01/2000
17Glioma (Gliomas)
12/2009 - 01/2000
7Glioblastoma (Glioblastoma Multiforme)
10/2012 - 01/2000
5Brain Neoplasms (Brain Tumor)
09/2001 - 01/2000
4Medulloblastoma
06/2009 - 07/2001
4Central Nervous System Neoplasms
09/2001 - 01/2000
2Astrocytoma (Pilocytic Astrocytoma)
09/2001 - 02/2000
1Neoplasm Metastasis (Metastasis)
09/2010
1Squamous Cell Carcinoma of Head and Neck
09/2010
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2010
1Hypoxia (Hypoxemia)
12/2009
1Hypertension (High Blood Pressure)
12/2009
1Ataxia Telangiectasia (Louis Bar Syndrome)
06/2009
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2001
1Ependymoma
07/2001
1Meningitis
05/2001
1Bilateral Hearing Loss
05/2001
1Neuroectodermal Tumors (Neuroectodermal Tumor)
05/2001
1Melanoma (Melanoma, Malignant)
05/2001
1Thrombocytopenia (Thrombopenia)
10/2000
1Neutropenia
10/2000
1Oligodendroglioma
08/2000
1Experimental Melanoma
06/2000
1Pathologic Processes
06/2000
1Carcinoma (Carcinomatosis)
01/2000

Drug/Important Bio-Agent (IBA)

7epidermal growth factor receptor VIIIIBA
09/2010 - 01/2000
6ErbB Receptors (EGF Receptor)IBA
09/2010 - 01/2000
5Monoclonal AntibodiesIBA
09/2010 - 03/2000
4Carmustine (FIVB)FDA Link
06/2009 - 01/2000
3Peptides (Polypeptides)IBA
10/2001 - 08/2000
3Irinotecan (Camptosar)FDA LinkGeneric
07/2001 - 01/2000
3AntigensIBA
09/2000 - 06/2000
2Bevacizumab (Avastin)FDA Link
10/2012 - 12/2009
2Epidermal Growth Factor (EGF)IBA
09/2010 - 06/2001
2Phosphotransferases (Kinase)IBA
06/2009 - 06/2007
2Glycoproteins (Glycoprotein)IBA
05/2008 - 06/2007
2Proteins (Proteins, Gene)FDA Link
06/2007 - 08/2000
2Amino AcidsFDA Link
10/2001 - 08/2000
2Procarbazine (Matulane)FDA Link
09/2001 - 07/2001
2CamptothecinIBA
07/2001 - 10/2000
2O(6)-benzylguanineIBA
10/2000 - 01/2000
2Temozolomide (Temodar)FDA LinkGeneric
10/2000 - 10/2000
2TenascinIBA
08/2000 - 03/2000
1Antineoplastic Agents (Antineoplastics)IBA
09/2010
1Cetuximab (Erbitux)FDA Link
09/2010
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2009
1Carbonic Anhydrase IXIBA
12/2009
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2008
1Oxidoreductases (Dehydrogenase)IBA
05/2008
1AldehydesIBA
05/2008
1Small Interfering RNA (siRNA)IBA
06/2007
1Cysteine (L-Cysteine)FDA Link
06/2007
1antineoplaston A10 (A 10)IBA
11/2001
1Pharmaceutical PreparationsIBA
11/2001
1irofulvenIBA
11/2001
1Hydroxyl RadicalIBA
09/2001
1carbazoleIBA
09/2001
1edotecarin (J 107088)IBA
09/2001
1Topoisomerase I InhibitorsIBA
09/2001
1Busulfan (Busulfex)FDA Link
07/2001
1cositecanIBA
07/2001
1Topotecan (Hycamtin)FDA LinkGeneric
07/2001
1AgarIBA
05/2001
1Sulfates (Sulfates, Inorganic)IBA
05/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2001
1Proteoglycans (Proteoglycan)IBA
05/2001
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2001
1Biological ProductsIBA
05/2001
1Iodine-131IBA
11/2000
1imidazoleIBA
10/2000
1Tumor Biomarkers (Tumor Markers)IBA
09/2000
1LigandsIBA
08/2000
1EpitopesIBA
06/2000
1Immunoglobulin G (IgG)IBA
06/2000
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2000
1CytokinesIBA
02/2000
1Cytotoxins (Cytolysins)IBA
01/2000
1AntibodiesIBA
01/2000
1Radioisotopes (Radionuclides)IBA
01/2000
1Cell Surface ReceptorsIBA
01/2000

Therapy/Procedure

8Therapeutics
10/2012 - 01/2000
3Drug Therapy (Chemotherapy)
12/2009 - 11/2000
3Immunotherapy
12/2000 - 06/2000
1Aftercare (After-Treatment)
05/2001
1Radiotherapy
05/2001
1Injections
03/2000